e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Scientific Year in Review
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determinants of lung cancer evolution: immune escape and inflammation
S. Janes (London, United Kingdom)
Source:
International Congress 2018 – Scientific Year in Review
Session:
Scientific Year in Review
Session type:
Year in review
Number:
3753
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Janes (London, United Kingdom). Determinants of lung cancer evolution: immune escape and inflammation. International Congress 2018 – Scientific Year in Review
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
From ineffective tumor immune response to immunomodulation in lung cancer
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017
Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020
Immunology and defence mechanism of the developing lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60
Year: 2006
The innate immune function of airway epithelial cells in inflammatory lung disease
Source: Eur Respir J 2015; 45: 1150-1162
Year: 2015
Ageing of the immune system: a contribution to lung disease?
Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung
Year: 2012
Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Immune system dysregulation in chronic lung disease
Source: Eur Respir J 2011; 38: 500-501
Year: 2011
How to define the immune status of lung cancer patient
Source: International Congress 2015 – Stop immune tolerance in lung cancer!
Year: 2015
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Epigenetic control of antiviral and innate immune response following viral infection in a lung epithelial model
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
Innate and adaptive immune response in lung diseases
Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases
Year: 2019
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006
Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
How infections can modify lung immunity
Source: Eur Respir J 2001; 18: 442-443
Year: 2001
How infections can modify lung immunity
Source: Guideline 2001
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept